Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Promega Introduces QuantiFluor ONE dsDNA System

Published: Friday, December 06, 2013
Last Updated: Thursday, December 05, 2013
Bookmark and Share
QuantiFluor ONE dsDNA system expands Promega’s nucleic acid quantitation offering.

Promega Corporation has announced the launch of the QuantiFluor® ONE dsDNA System, a sensitive, dsDNA-specific fluorescent dye suitable for use in both research and clinical workflows.

The new dye system is integrated into the new Promega Quantus™ Fluorometer and GloMax® detection instruments, but is compatible with any fluorometer capable of measuring the appropriate fluorescence excitation and emission spectra.

The QuantiFluor ONE dsDNA System is supplied in “add-and-read” format, enabling users to simply quantitate even low concentration samples with confidence, and without dilutions or additional tubes.

The dye system has significantly increased sensitivity compared to absorbance based systems and is highly specific to dsDNA, showing minimal binding to ssDNA, RNA, protein and interfering compounds.

The QuantiFluor ONE dsDNA System expands the company’s range of nucleic acid quantitation reagents and instrumentation, which includes the recently launched Quantus Fluorometer for highly sensitive (up to 40,000x higher than absorbance-based methods) quantitation of dsDNA, ssDNA, and RNA.

Quantus’ increased sensitivity and range leads to higher success rates in downstream applications such as PCR cloning, transfection and next-generation sequencing. Quantus is also the ideal solution when working with samples such as FFPE tissue which contain low levels of nucleic acid, enabling users to move on to downstream detection assays knowing that DNA or RNA is present.

Other dyes for use with Quantus include dsDNA System, ssDNA System, and RNA System. Quantus is optimized for use with QuantiFluor Dyes, but is also compatible with other fluorescent quantitation dyes.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Promega to Break Ground for New Processing and Manufacturing Facility
Facility will allow for efficiency improvements for processing, packaging, staging and shipping products.
Monday, July 07, 2014
Scientific News
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Exploring the Causes of Cancer
Queen's research to understand the regulation of a cell surface protein involved in cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
RNA-Based Drugs Give More Control Over Gene Editing
CRISPR/Cas9 gene editing technique can be transiently activated and inactivated using RNA-based drugs, giving researchers more precise control in correcting and inactivating genes.
University of Glasgow Researchers Make An Impact in 60 Seconds
Early-career researchers were invited to submit an engaging, dynamic and compelling 60 second video illuminating an aspect of their research.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
Dead Bacteria to Kill Colorectal Cancer
Scientists from Nanyang Technological University (NTU Singapore) have successfully used dead bacteria to kill colorectal cancer cells.
CRISPR-Cas9 Gene Editing: Check Three Times, Cut Once
Two new studies from UC Berkeley should give scientists who use CRISPR-Cas9 for genome engineering greater confidence that they won’t inadvertently edit the wrong DNA.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos